Abstract -Our previous studies with mice showed that chronic ethanol (EtOH) administration affected the incorporation of unsaturated free fatty acids (FFA) into four major brain phospholipids (PL). In the current study, we investigated the effects of ganglioside GMl pretreatment on EtOH-induced changes in the incorporation of various FFA into cerebral PL in mice. Consistent with our earlier fmdings, the results suggest that chronic EtOH exposure alters the incorporation of unsaturated fatty acids into phosphatidylinositol (PI), phosphatidylserine, and phosphatidylcholine (PC), but not into phosphatidylethanolamine (PE). No significant differences were observed with stearic acid. The ganglioside GMl treatment led to increased incorporation of linoleic acid (LA) into PE and PC and appeared to enhance the EtOH-produced effects especially for docosahexaenoic acid (DHA) and to a lesser extent for oleic acid, LA, and arachidonic acid, when compared to the untreated control group. However, when comparison was made with the EtOH-alone group, significant differences were observed only with DHA incorporation and mainly into PE and PI. Thus acyltransferases may play an important role in membrane adaptation to the injurious effects of EtOH and GMl appears to enhance selective incorporation of FFA into membrane PL; a process that may represent a repair mechanism.
INTRODUCTION
The traditional view of many alcohol actions is related to its ability to disorder cell membrane structure and thereby alter the physical properties of the membrane. The interaction of ethanol (EtOH) with plasma membranes may result in changes in the hydrophobic regions of membrane lipids and proteins (Hunt, 1985) . In mammals, these membrane alterations are manifested, following either chronic or acute EtOH exposure (Littleton and John, 1977; Sun and Sun, 1979; Ailing et al., 1982; Ponnappa et al., 1982; Waring et al., 1982; Wing et al., 1982; Harris et al., 1984; Laposata and Lange, 1987; Hungund et al., 1988; Ulrichsen et al., \991; Johnson et al., 1992; Wood et al., 1993) . The adaptation (tolerance) observed after chronic EtOH exposure was explained by the development of resistance to the disordering
•Author to whom correspondence should be addressed at: NYS Psychiatric Institute at NKI, 140 Old Orangeburg Road, Orangeburg, NY 10962, USA. effects of EtOH on the membrane (Ponnappa et al., 1982; Waring et al., 1982; Harris et al., 1984) . Various studies have shown that EtOH exposure induces changes in various lipid constituents of the membrane, such as cholesterol (Johnson et al., 1992; Wood et al., 1993) , cholesterol esters (Wing et al., 1982) fatty acid ethyl esters (Laposata and Lange, 1987; Hungund et al., 1988) and particularly the fatty acyl composition of membrane phospholipids (PL) (Littleton and John, 1977; Sun and Sun, 1979; Ailing et al., 1982; Ulrichsen et al., 1991) . It is conceivable that many of the actions of EtOH leading to the disordering of PL acyl chains in the membrane and the subsequent development of resistance to EtOH, are associated with changes in enzymes that regulate PL metabolism in cellular membranes, such as phospholipase A2 (PLA2) and acyltransferases. These enzymes may participate in several key events that determine the turnover of PL in cell membranes i.e. the deacylation and reacylation cycle, the biosynthesis of eicosanoids (Van Den Bosch, 1980; Waite, 1987) and signal transduction Z. ZHENG et a!.
across the membrane (Creutz, 1981; Frye and Holz, 1985; Karli et al., 1990; Bonventre, 1992) .
Ganglioside GM1 (GM1), a constituent of the central nervous system, when administered exogenously, is shown to provide neuroprotection against a variety of nervous system injuries both in vivo and in vitro (Skaper and Leon, 1992) . The exogenous GM1 reduces the extent of neural injury resulting from insults such as trauma, ischaemia and glutamate toxicity (Magal et al., 1990; Skaper et al., 1991; Bonheur et al., 1994) . Our recent studies with gangliosides have shown that treatment with GM1 resulted in a significant reduction of the deleterious effects of EtOH in both adult animals and developing fetuses (Hungund et al., 1990 (Hungund et al., , 1991 Hungund and Mahadik, 1993 ). An increase of PLA2 activity in synaptosomal membranes after exposure to EtOH was reported by John et al. (1985) and by our group (Hungund et al., 1994) . We have also shown that the effect of EtOH on PLA2 activity was significantly attenuated by pre-treatment with GM1 (Hungund et al., 1994) . Thus GM1 may reduce toxic effects by inhibiting EtOH-induced membrane alterations resulting from PLA2 activation. Since EtOH increases PLA2 activity in synaptic membranes, the resulting lysophospholipids may impair cellular functions and need to be reacylated. Therefore, it is reasonable to expect an increase in the activity of acyltransferase enzymes in synaptosomal membranes from animals that have been exposed to EtOH. Recently we have reported that chronic EtOH exposure has a significant effect on the incorporation of various free fatty acids (FFA) into membrane PL (Zheng et al., 1996) . Since EtOH affects the incorporation of various acyl moieties into individual PL in synaptosomal membranes, we directed our attention in the present study, to the possible interaction of GM1 with such EtOH effects. Our results suggest that GM1 may exert its neuroprotective effect by enhanced reacylation of lysophospholipids resulting from EtOH-induced activation of PLA2.
MATERIALS AND METHODS

Materials
Ganglioside GM1 was obtained from Fidia Corp. (Italy). [4,5- 3 H]Docosahexaenoic acid (DHA) (60 Ci/mmol), [5, 6, 8, 9, 11, 12, 14, 
Etnanol and GM1 administration
Male Swiss-Webster mice (25-30 g) were chronically exposed to EtOH by an inhalation procedure for 3 days. An i.p. injection of pyrazole (68 mg/kg) was given daily. This dose of pyrazole is known to inhibit alcohol dehydrogenase and stabilize blood-alcohol levels (Goldstein, 1972; Zheng et al., 1996) . Ganglioside GM1 (10 mg/kg) was administered i.m. 24 h before the initial exposure to EtOH and then once daily 1 h before the injection of pyrazole. The inhalation procedure employed in the current study has been shown to maintain constant blood-alcohol levels throughout the experimental period and following this procedure animals have been shown to be EtOH-tolerant and -dependent within 72 h of exposure to EtOH vapour (Goldstein, 1972) . Control animals were treated under identical conditions except for the absence of EtOH from the inspired air. All the animals including the controls received daily pyrazole injections. Blood-EtOH levels were determined by the enzymatic method (Lundquist, 1959) . Animals were killed by decapitation and their brains were removed and immediately processed for the preparation of synaptosomes.
Synaptosomal preparation
Crude synaptosomal fraction was prepared according to the procedure described by Jones and Matus (1974) . Three brains were pooled for each preparation. Brains were homogenized in 9 vol. of 0.32 M sucrose and centrifuged at 800 g for 20 min. The supernatant was removed and centrifuged at 15 000g for 20 min to obtain a pellet (P2). The P2 fraction was washed and resuspended with Krebs-Ringer buffer (KRB). Protein was estimated by the method of Lowry et al. (1951) .
FFA incorporation and lipid extraction
Incorporation was performed as described previously (Barkai and Murthy, 1988; Zheng et al., 1996) . Briefly, each assay tube contained freshly prepared membrane suspension (1 mg of protein) in 0.45 ml KRB (pH7.4) and was preincubated at 37 C C for 10 min. Incorporation of fatty acid was initiated by the addition of 50 |il of KRB containing isotope labelled fatty acid (0.25 uCi), ATP (25 mM), Mg 2+ (10 mM) and Co A (1 mM) and the mixture was incubated at 37°C in a shaking water bath for an additional 10 min. The reaction was terminated by adding 1.5 ml of chloroform-methanol (1:2, by vol.), followed by the addition of 1 ml of chloroform and 0.5 ml of distilled water. The tubes were then vortexed and centrifuged at 180 g for 10 min for separation of the organic and aqueous phases. The lower organic phase was removed and evaporated to dryness under a stream of N2 and the lipids were redissolved in 50 ul of chloroform. Antioxidant butylated hydroxy toluene (BHT) was present in the extraction medium and during storage throughout the procedure.
PL separation and radioactivity determination
PLs were purified by column chromatography according to the procedure described by Vance and Sweeley (1967) . Briefly, 1 g of silicic acid (Bio-Rad, Richmond, CA, USA) was activated for at least 12 h at 80°C and suspended immediately in diethyl edier. The slurry was applied to a small column, the adsorbent was washed with 10 ml of chloroform before the solution of crude total lipids was applied to the column. The column was then eluted with 15 ml of chloroform and 15 ml of acetone-methanol (9:1 by vol.) respectively. Finally die column was eluted with 15 ml of methanol to obtain the fraction of total PL. The eluate containing PL was dried under N 2 and the PL residue was dissolved in chloroform-methanol (2:1) and chromatographed on HPTLC plates (E. Merck, Darmstadt, Germany) to separate the individual PLs. The solvent system used was chloroform-methyl acetate-n-propanol-methanol-0.25% KC1 (25:25:25:10:9, by vol.) (Vitiello and Zanetta, 1978) . After visualization of PL with iodine vapour, PL spots were scraped into scintillation vials and mixed with 100 ul of tissue solubilizer. The vials were incubated at 50°C for 30 min and cooled to 4°C. Radioactivity incorporated into individual PL was estimated by scintillation counting after correction for efficiency and quenching. The specific activity values of the exogenously added substrate were used to convert the incorporated radioactivity to mass. The radioactivity incorporated in the EtOH, GM1 and GM1 + EtOH group membranes were compared with the radioactivity incorporated in the control group membranes and expressed as a percentage of the control group.
Statistical analysis
Each assay was performed with four to six preparations and analysed in triplicate. Data were subjected to multiple analyses of variance (MANOVAs) for examination of statistical significance. To reduce problems related to testing a large number of hypotheses, the data were analysed as five 2x2 MANOVAs for each fatty acid. Within each MANOVA, statistically significant univariate tests were reported only when the corresponding multivariate test was statistically significant.
RESULTS
Animal treatment and membrane preparation
The daily blood-EtOH levels ranged from 180 to 260 mg/dl. No significant difference in bloodEtOH concentrations was observed between die EtOH-alone group (235 ± 7 mg/dl) and the GM1 + EtOH-group (241 ± 6 mg/dl). The crude synaptosomal membrane preparation contained mitochondria, myelin, and synaptosomal membranes. A similar preparation was employed for fatty acid incorporation in our earlier studies (Barkai and Murthy, 1988; Zheng et al, 1996) . 
Effects of chronic EtOH exposure on FFA incorporation into membrane PL
The rates of FFA incorporation into various PLs of crude synaptosomal preparations of control brains are presented in Table 1 . The results suggest that the incorporation of fatty acids into four major PLs varied from 9.6 fmol/min/mg of protein for DHA into PI to 795.8 fmol/min/mg of protein for LA into PC. These results are consistent with our previously reported findings (Zheng et al., 1996) . The effects of EtOH on these rates are summarized in Fig. 1 . There was a significant effect of EtOH on the incorporation of oleic acid, LA, AA, and DHA into membrane PL compared with the control group. Chronic exposure to EtOH led to an alteration in the incorporation patterns of unsaturated fatty acids into phosphatidylinositol (PI), phosphatidylserine (PS), and phosphatidylcholine (PC) but not into phosphatidylethanolamine (PE). Chronic EtOH exposure increased the incorporation of oleic acid into PI and PS, LA into PS and PC, DHA into PS, AA into PC, and decreased the incorporation of AA into PI compared with the control group. No significant differences were observed for stearic acid.
Effects of GM1 pretreatment on FFA incorporation into membrane PL
Although pretreatment with GM1 alone enhanced the incorporation of LA into PE and PC, its effect on the incorporation of stearic, oleic, AA, and DHA was insignificant compared to the control membrane (Fig. 2) .
Treatment of animals with GM1 prior to EtOH exposure significantly altered incorporation of various FFA into individual PL when compared with untreated controls, e.g. oleic acid incorporation was significantly increased into PE, PI, and PS. Enhanced incorporation of other fatty acids tested was also observed; LA into PS and PC, DHA into PE, PI, PS and PC, and AA into PC. A significant decrease in the incorporation of AA into PI was evident (Fig. 3) . When the statistical analysis was performed comparing EtOH vs GMl + EtOH, significant differences were only observed in the incorporation of DHA, mainly into PE and PI (Fig. 4) . No difference in the rate of incorporation of other FFA was evident. These results suggest that GMl enhances EtOH effects on the incorporation of selective FFA.
DISCUSSION
Many studies have provided evidence suggesting that changes in PL acyl chains of neuronal membranes are associated with adaptation to chronic EtOH exposure (Sun and Sun, 1979; Harris et al., 1984; Ulrichsen, 1991) . It can be inferred from these studies that changes in enzymes governing PL metabolism may partially explain the adaptation mechanism. Although there are numerous studies directed towards analysis of alterations in PL acyl composition, such studies are mainly concerned with total PLs and do not provide information about reacylation patterns of individual PL after chronic EtOH exposure. Consistent with our earlier findings, the results described in the present study suggest that EtOH exposure altered the incorporation of unsaturated FFA into PI, PS, and PC, but not into PE. No significant differences were observed for stearic acid incorporation. The question of whether enhancement of reacylation by EtOH may involve specific acyltransferases should be addressed, because alterations in the composition of fatty acids in the sn-2 position of individual PL could play an important role in the adaptation of the membranes to EtOH exposure. The observed preferential incorporation might be explained by our earlier findings, which showed that chronic EtOH results in activation of membrane PLA2, an enzyme responsible for deacylation of sn-2 fatty acyl chains of PL. Specificity of acyltransferases in crude and purified synaptosomal preparations for the transfer of fatty acids into PC and PI has been reported (Strosznajder et al., 1983; Deka et al., 1986; Sanjanwala et al., 1989; Mohn et al., 1992) . These studies support the possibility that there may be more than one PLA2 enzyme requiring a specific PL substrate with a defined unsaturated FFA in the sn-2 position of PL and/or more than one acyltransferase participating in the reacylation event. Thus EtOH can induce activa-tion of certain PLA2, as required for adaptation to the continuous presence of EtOH, and may further lead to activation of selective acyltransferase enzymes.
Our study also examined the possible mechanism of the protective effect of exogenous GM1. Among the many species of gangliosides and glycolipids tested, GM1 was shown to be the most effective in reducing EtOH-induced biochemical and behavioural effects (Klemm et al., 1988; Hungund et al, 1990; Wallis et al, 1995) . Therefore in the current study the effect of GM1 only was tested. To be consistent with our previous studies on PLA2, and acyltransferases (Hungund et al, 1994; Zheng et al, 19% ) the preparation of crude synaptosomes employed in the present studies followed a similar experimental protocol. The GM1 treatment prior to EtOH exposure resulted in an enhanced incorporation of selected FFA into membrane PL as compared to untreated controls. However, when the comparison was made with EtOH treatment, the enhanced incorporation was seen only with DHA. It is of interest to note that this increased incorporation of DHA was limited to PE and PI. Our findings suggest that, unless there is disorganization of the PL bilayer, GM1 by itself had no significant effect on PL reacylation. However, when there is a disruption of membrane acyl groups, GM1 might initiate the repair mechanism by enhancing incorporation of selective FFA into lysophospholipids produced by PLA2 activation. It should be mentioned mat the ability of GM1 to restore the altered fatty acyl composition resulting from ischaemia has previously been reported by Mahadik et al. (1993) . How GM1 elicits its neuroprotective effect has not been established. GM1 has been shown to reduce neurotoxic levels of tissue Ca 2+ which increase after central nervous system injury (Leskawa et al, 1989; Schengrund, 1990; Mahadik et al, 1992) . This increased Ca 2+ influx induces membrane phospholipid changes that include the release of membrane fatty acids, probably through PLA2 activation, thereby leading to a deficiency in membrane structure/function . The neuroprotective effect of GM1 may be based on its ability to inhibit EtOH-induced translocation of cytosolic PLA2 to the membrane as demonstrated by Hungund et al. (1994) and/or by enhanced reacylation of membrane PL as shown here. This protective effect may be initiated by direct insertion of GM1 into the membrane PL bilayer thereby conferring rigidity to the membranes. A portion of exogenously administered GM1 has been shown to pass the blood-brain barrier and to become incorporated into neuronal membranes (Kanda et al., 1982; . The implication of the observed effect of GM1 on the deacylation/ reacylation mechanism is that GM1 treatment may be used therapeutically to treat the effects of alcohol use and abuse.
However, a number of other mechanisms which may be involved in reacylation reactions should be addressed. The activation of acyltransferase may depend on many factors, one of which could be the production of a lysophospholipid which may be a preferred substrate for reacylation with selective FFA. Lysophospholipids can also be acylated by a coenzyme-A-independent transacylase reaction. A transacylation reaction may also be able to convert two lysophospholipids transferring an acyl chain from the sn-1 position to the sn-2 position of a second lysophospholipid acceptor. It would be interesting to study whether and how GM1 modulates these parameters. However, additional studies with purified membranes using exogenously added GM1 and lysophospholipids would lead to a better understanding of the kinetics of reacylation and the mechanism of the neuroprotective effects of GM1.
